UCB S A/ BE0003739530 /
| 2024-04-26 5:27:02 PM | Chg. +5.1800 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 133.6800USD | +4.03% | 270 Turnover: 36,093.6000 |
-Bid Size: - | -Ask Size: - | 25.35 bill.USD | - | - |
GlobeNewswire
04-15
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire
04-01
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
03-25
Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire
03-05
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
03-05
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
02-28
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
02-16
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire
02-08
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire
01-22
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire
01-15
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire
01-07
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire
2023-12-08
General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs
GlobeNewswire
2023-11-14
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
GlobeNewswire
2023-11-14
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
2023-11-13
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanom...
GlobeNewswire
2023-11-07
US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire
2023-11-07
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Result...
GlobeNewswire
2023-11-06
Diaccurate Announces the Appointment of Scott Filosi as CEO and Corporate Name Change to Evexta Bio
GlobeNewswire
2023-11-04
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cel...
GlobeNewswire
2023-10-23
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study...
GlobeNewswire
2023-10-18
Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of ...
GlobeNewswire
2023-10-18
Tonix Pharmaceuticals Announces Publication of Data in the Journal Nature Involving TNX-1500 (Fc-mod...
GlobeNewswire
2023-10-10
Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director
